Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F3 | P13726 | 3/20 | 0.72 |
| ▸ | THRB | P10828 | 1/20 | 0.70 |
| ▸ | ATM | Q13315 | 1/20 | 0.70 |
| ▸ | GSK3B | P49841 | 2/20 | 0.68 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.66 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.66 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.66 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.66 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.66 |
| ▸ | BACE1 | P56817 | 1/20 | 0.62 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.60 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.60 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.60 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.60 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.60 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.60 |
| ▸ | BCHE | P06276 | 1/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.60 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.60 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2009524 | 1.00 | F3 (0.72) | F3THRBATMGSK3BHDAC3 | |
| SCHEMBL13067871 | 0.95 | HDAC8 (0.69) | F3THRBATMGSK3BHDAC3 | |
| SCHEMBL10399152 | 0.87 | HDAC8 (0.63) | F3THRBATMGSK3BHDAC3 | |
| SCHEMBL16410058 | 0.87 | HDAC8 (0.63) | F3THRBATMGSK3BHDAC3 | |
| SCHEMBL2744101 | 0.84 | F3 (1.00) | F3THRBATMGSK3BHDAC3 | |
| SCHEMBL2744098 | 0.84 | F3 (1.00) | F3THRBATMGSK3BHDAC3 | |
| SCHEMBL9073430 | 0.84 | F3 (0.78) | F3THRBATMGSK3BHDAC3 | |
| SCHEMBL9073433 | 0.84 | F3 (0.78) | F3THRBATMGSK3BHDAC3 | |
| SCHEMBL14331811 | 0.84 | F3 (1.00) | F3THRBATMGSK3BHDAC3 | |
| SCHEMBL1450230 | 0.83 | F3 (0.52) | F3HDAC3HDAC1HDAC2HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102005220-B | Compositions, optical data storage media and methods for using the optical data storage media | GEN ELECTRIC | 2015-06-03 | — | — | CN | claimed |
| CN-102005213-B | Optical data storage media and methods for using the same | GEN ELECTRIC | 2015-05-13 | — | — | CN | claimed |
| CN-102005222-B | Optical data storage method | GEN ELECTRIC | 2014-07-23 | — | — | CN | claimed |
| EP-1740152-B1 | POLY(SILSESQUIOXANE) SPHERICAL PARTICLE CONTAINING ULTRAVIOLET LIGHT-ABSORBING GROUP AND MANUFACTURING METHOD THEREOF | SAIMDANG COSMETICS CO LTD (KR) | 2012-12-26 | — | — | EP | claimed |
| CN-102592613-A | Optical data storage media and methods for using the same | GEN ELECTRIC | 2012-07-18 | — | — | CN | claimed |
| US-20120147724-A1 | OPTICAL DATA STORAGE MEDIA AND METHODS FOR USING THE SAME | GENERAL ELECTRIC COMPANY (US) | 2012-06-14 | — | — | US | claimed |
| JP-4828407-B2 | — | — | 2011-11-30 | — | — | JP | claimed |
| CN-102005222-A | Compositions, optical data storage media and methods for using the optical data storage media | GEN ELECTRIC | 2011-04-06 | — | — | CN | claimed |
| CN-102005220-A | Compositions, optical data storage media and methods for using the optical data storage media | GEN ELECTRIC | 2011-04-06 | — | — | CN | claimed |
| CN-102005213-A | Optical data storage media and methods for using the same | GEN ELECTRIC | 2011-04-06 | — | — | CN | claimed |
| WO-2008062424-A2 | SUBSTITUTED 4,5-DIHYDRO-1H-PYRAZOLE DERIVATIVES AS CANNABINOID MODULATORS | CADILA HEALTHCARE LIMITED (IN) | 2008-05-29 | — | — | WO | claimed |
| US-20070249854-A1 | Poly(Silsesquioxane) Spherical Particle Containing Ultraviolet Light-Absorbing Group and Manufacturing Method Thereof | SAIMDANG COSMETICS CO., LTD. (KR) | 2007-10-25 | — | — | US | claimed |
| EP-1594869-A2 | 3-SUBSTITUTED-2(ARYLALKYL)-1-AZABICYCLOALKANES AND METHODS OF USE THEREOF | Targacept, Inc. (US) | 2005-11-16 | — | — | EP | claimed |
| WO-2004076449-A2 | 3-SUBSTITUTED-2(ARYLALKYL)-1-AZABICYCLOALKANES AND METHODS OF USE THEREOF | TARGACEPT, INC. (US) | 2004-09-10 | — | — | WO | claimed |
| EP-0218622-B1 | AMIDES OF PARA-METHOXYCINNAMIC AND UTILIZATION THEREOF AS SOLAR FILTERS | Robert, Dominique (FR) | 1991-07-10 | — | — | EP | claimed |
| CN-122095297-A | Composition for forming cured film, alignment material, and phase difference material | — | 2026-05-26 | — | — | CN | disclosed |
| WO-2025088969-A1 | COMPOSITION FOR FORMING CURED FILM, CURED FILM, ALIGNMENT MATERIAL, AND RETARDATION MATERIAL | 日産化学株式会社 | 2025-05-01 | — | — | WO | disclosed |
| US-4600777-A | Method of preparing 1-alkyl-7-oxodecahydroquinolines, and cis(±) and tran(±)isomers so prepared | ELI LILLY AND COMPANY (US) | 1986-07-15 | — | — | US | disclosed |
| EP-0001997-B1 | ELECTRON BEAM-CURABLE PHOTORESIST LACQUERS | BAYER AG (DE) | 1981-02-11 | — | — | EP | disclosed |
| EP-0001997-A1 | Electron beam-curable photoresist lacquers | BAYER AG (DE) | 1979-05-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070249854-A1 | Poly(Silsesquioxane) Spherical Particle Containing Ultraviolet Light-Absorbing Group and Manufacturing Method Thereof | STS, PARG, SBDS | F3 1935/4885THRB 4676/4885ATM 1841/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.